Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEET

v3.21.1
CONDENSED BALANCE SHEET - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash $ 3,841,936  
Prepaid expenses and other current assets 705,724  
Total Current Assets 4,547,660  
Deferred offering costs   $ 197,790
Cash and marketable securities held in Trust Account 345,006,966  
TOTAL ASSETS 349,554,626 197,790
Current liabilities    
Accrued expenses 10,000 6,093
Accrued offering costs 316,999 120,540
Promissory note - related party   52,250
Total Current Liabilities 326,999 178,883
Warranty liability 13,703,000  
Deferred underwriting fee payable 12,075,000  
Total Liabilities 26,104,999 178,883
Commitments and contingencies
Stockholder's Equity    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 478,279 24,137
Accumulated Deficit 4,520,599 (6,093)
Total Stockholder's Equity 5,000,007 18,907
TOTAL LIABILITIES AND STOCKHOLDER'S EQUITY 349,554,626 197,790
Class A Common Stock    
Stockholder's Equity    
Common stock 266  
Class A Common Stock Subject to Redemption    
Current liabilities    
Class A ordinary shares subject to possible redemption 31,844,962 and no shares at $10.00 per share redemption value as of March 31, 2021 and December 31, 2020, respectively 318,449,620  
Class B Common Stock    
Stockholder's Equity    
Common stock $ 863 $ 863